HIGHLIGHTS
- who: Viktoria Stu00fchler from the Department of Urology, University Hospital Tuebingen, Eberhard-Karls-University Tuebingen, Tu00fcbingen, Germany have published the research: Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies, in the Journal: (JOURNAL)
- what: The authors found that complete metastasectomy was generally associated with improved CSS compared with no metastasectomy in the era of targeted therapy and even the availability of IO-based therapy in univariate and multivariate analyses.
- how: The results are consistent with those of Li et_al showing an association . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.